MYTELASE 10 MG TBL NOB 50

What is the maximum co-payment for MYTELASE?

If the insurance company contributes, the maximum co-payment is 442,46 Kč. The maximum pharmacy price is 570,86 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, zkontrolujte ale specializaci předepisujího lékaře níže.

Does MYTELASE have a counted co-payment set?

Yes, the medicine has a counted co-payment of 442,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

128,40 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Ambenonium je hrazeno u pacientů s myasthenia gravis vyžadujících léčbu inhibitory cholinesterázy při neúčinnosti či nesnášenlivosti pyridostigminu.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe MYTELASE?

neurology, pediatric neurology

What is the composition of MYTELASE?

Ambenonium-chlorid (10 mg), monohydrát laktosy, kukuřičný škrob, dihydrát hydrogenfosforečnanu vápenatého, magnesium-stearát. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Documents could not be found

Which medicines are similar to MYTELASE?

The medicine belongs to ATC group N07AA30 – AMBENONIUM. Medicines with the same active substance can be found here.

Who manufactures MYTELASE?

Neuraxpharm Bohemia s.r.o., Praha (CZ)

Is the medicine in shortage?

The latest report from the manufacturer is from 19. 9. 2023. Production was terminated with effect from 6. 9. 2023. The manufacturer lists medicines with the following code as a potential substitute: